Author: WTN News

When it comes to venture capital, higher interest rates aren't necessarily a death sentence, according to columnist Ogan Gurel. In this edition of Med Tech Futures, he contends that higher rates tend to point investors toward higher potential return, higher-risk investments. That means the life...

The federal government has awarded two more Small Business Innovation Research grants to NeoClone Biotechnology for its work in developing antibody microarray tests that could improve the detection of ovarian cancer. The grants, awarded by the National Cancer Institute, total $250,000. ...

The hits just keep coming with state information technology projects. The latest problem involves a $32.3 million computer system for the state's Medicaid health claims. The project, which was supposed to produce administrative savings, will be delayed at least 10 months, according to a report...

Taking aim at IT workorce and other labor practices, columnist James Carlini assails the practice of "labor dumping," which like product dumping is eroding the economic stability of the middle class. In this edition of Carlini's Comments, he explains why labor dumping is yet another...

There is a multi- billion dollar gap between the Senate and Assembly budgets, but the real bargaining over the state's two-year spending blueprint has begun in conference committee. In this edition of Inside Wisconsin, columnist Tom Still would like to see lawmakers follow a few...

Background checks using fingerprints might never be the same if a Montello, Wis. business continues to gain traction in the biometrics market. Fahlgreen Solutions, an early-stage company, hopes to capture a good share of that market, which could grow to $6 billion worldwide by 2010...

Unlike the biotech industry, where the Midwest is playing catch-up to the coasts, the Midwest's nanotech industry is robust and on par with developments in other leading areas in the U.S. In this edition of Yer Biotech Blues, columnist Michael Rosen touts the multiple examples...